Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised FACT-Finder on its acquisition of real-time AI-personalization vendor Loop54
Mandate

Vinge advised FACT-Finder on its acquisition of real-time AI-personalization vendor Loop54

November 11, 2021 M&A Intellectual Property Commercial Agreements Employment and Benefits

Vinge advised FACT-Finder on its acquisition of real-time AI-personalization vendor Loop54 making it one of the first major consolidations of leading e-commerce SaaS solutions in search, merch and personalization.

The merging of their proprietary algorithms will enable FACT-Finder customers to provide digital experiences that are unlike any other on the market and further expand FACT-Finder's international presence.

Vinge’s team consisted of responsible partner Matthias Pannier and associates Vilhelm Rondahl, Gustav Persson, Ebba Nyberg (M&A), Isabell Nielsen, Karl-Gustaw Tobola, Karolina Fuhrmann (Commercial Agreements/IT), Sofia Bergenstråhle (Intellectual Property), Carl Östlund (Employment), Karl-Hugo Engdahl (GDPR) and Ulf Pyk (Real Estate).

 

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026